• PA
    PA School SurvivalDidactic Year
Subjects
  • 📖Medical Terminology
  • 🦴Gross Anatomy
    • Study Playbook
    • By Region
    • PNS Chart
    • My Lectures
    • Practice
  • 🧬Immunology & Genetics
    • Study Playbook
    • By Topic
    • My Lectures
    • Practice
  • 🧪Physiology
    • Study Playbook
    • By System
    • My Lectures
    • Practice
My material
  • 🗂️My Library
  • ✍️Notes & Sketches
Study Tools
  • 🎓Flashcards
  • 📡To revisit
  • 🗓️Calendar
  • 📈Progress
  • ✅Prep Rounds
  • 🧬Body Systems
  • 💊Pharmacology
  • 🔗Offsite Resources
  • 🧭Guide & FAQ
  • 💡
    Suggest a FeatureLet us know what we can do better — we genuinely want to help you in class.
PANCE Body Systems
  • 🫀Cardiovascular
    11%
  • 🫁Pulmonary
    9%
  • 🍎Gastrointestinal/Nutrition
    8%
  • 💪Musculoskeletal
    8%
  • 🧠Neurology
    7%
  • 🦠Infectious Disease
    7%
  • 💭Psychiatry/Behavioral
    7%
  • 🤰Reproductive
    7%
  • 🦋Endocrine
    6%
  • 👁️Eyes/Ears/Nose/Throat
    6%
  • 🩸Hematology
    5%
  • 🫘Renal
    5%
  • 💧Genitourinary
    4%
  • 🖐️Dermatology
    4%
Weights are study aids — verify each exam cycle.
⌘K
NotesPricingSign in
About·Tools·Terminology·Anatomy playbook·Anatomy by region·Immunology & genetics·Immunology playbook·Physiology·Physiology playbook·Privacy Policy·Terms of Service·PANCE Blueprint

PANCE® is a registered trademark of the National Commission on Certification of Physician Assistants (NCCPA). This application is an independent study resource and is not affiliated with, sponsored by, or endorsed by the NCCPA.

For educational use only. Content is AI-generated, may contain errors, and is not medical advice — always verify against current primary sources and faculty guidance before clinical use.

HomeEndocrineType 2 Diabetes Mellitus
🦋

Type 2 Diabetes Mellitus

Endocrine · ~6% of blueprint
🔬Pathophysiology
Insulin resistance + relative insulin deficiency → chronic hyperglycemia.
🩺Signs & Symptoms
Polyuria, polydipsia, polyphagia, fatigue, blurred vision; often asymptomatic early.
🎯Gold Standard Diagnosis
HbA1c ≥6.5%, fasting glucose ≥126 mg/dL, or 2-hour OGTT ≥200 (confirm on repeat).
💊First-line Treatment
Lifestyle + person-centered choice; metformin if glucose lowering is the sole issue. ASCVD/HF/CKD: SGLT2i or GLP-1 RA.
Drug cardsMetforminEmpagliflozinSemaglutideGlipizide
High-Yield Pearl

SGLT2 inhibitors and GLP-1 agonists give cardiovascular & renal benefit beyond glucose lowering.

Sources

Reviewed September 2026
  1. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026 — American Diabetes Association, 2026
  2. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2026 — American Diabetes Association, 2026
  3. StatPearls: Type 2 Diabetes (substituted - guideline body unreachable) — StatPearls Publishing, 2026

Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.

More Endocrine conditions

  • Hyperthyroidism (Graves Disease)
  • Hypothyroidism
All Endocrine